In addition to maintaining the GenBank(R) nucleic acid sequence database, the National Center for Biotechnology Information (NCBI) provides data analysis and retrieval resources for the data in GenBank and other biological data made available through NCBI's website. NCBI resources include Entrez, PubMed, PubMed Central, LocusLink, the NCBI Taxonomy Browser, BLAST, BLAST Link (BLink), Electronic PCR, OrfFinder, Spidey, RefSeq, UniGene, HomoloGene, ProtEST, dbMHC, dbSNP, Cancer Chromosome Aberration Project (CCAP), Entrez Genomes and related tools, the Map Viewer, Model Maker, Evidence Viewer, Clusters of Orthologous Groups (COGs) database, Retroviral Genotyping Tools, SARS Coronavirus Resource, SAGEmap, Gene Expression Omnibus (GEO), Online Mendelian Inheritance in Man (OMIM), the Molecular Modeling Database (MMDB), the Conserved Domain Database (CDD) and the Conserved Domain Architecture Retrieval Tool (CDART). Augmenting many of the web applications are custom implementations of the BLAST program optimized to search specialized data sets. All of the resources can be accessed through the NCBI home page at: http://www.ncbi.nlm.nih.gov.

/pdf/database-resources-of-the-national-center-for-biotechnology-36jlaw3fxd.pdf

Database resources of the National Center for Biotechnology Information

Understanding the factors that determine the rate at which genomes generate and fix mutations provides important insights into key evolutionary mechanisms. We review our current knowledge of the rates of mutation and substitution, as well as their determinants, in RNA viruses, DNA viruses and retroviruses. We show that the high rate of nucleotide substitution in RNA viruses is matched by some DNA viruses, suggesting that evolutionary rates in viruses are explained by diverse aspects of viral biology, such as genomic architecture and replication speed, and not simply by polymerase fidelity.

Rates of evolutionary change in viruses: patterns and determinants.

Influenza epidemics cause morbidity and mortality worldwide (4). Each year in the United States, more than 200,000 patients are admitted to hospitals because of influenza and there are approximately 36,000 influenza-related deaths (14). In recent years, several subtypes of avian influenza viruses have jumped host species to infect humans. The H5N1 subtype, in particular, has been reported in 328 human cases and has caused 200 human deaths in 12 countries (World Health Organization, http://www.who.int/csr/disease/avian_influenza/country/cases_table_2007_09_10/en/index.html). These viruses have the potential to cause a pandemic in humans. Antiviral drugs and vaccines must be developed to minimize the damage that such a pandemic would bring. To achieve this, it is vital that researchers have free access to viral sequences in a timely fashion, and sequence analysis tools need to be readily available.

Historically, the number of influenza virus sequences in public databases has been far less than those of some well-studied viruses, such as human immunodeficiency virus. The number of complete influenza virus genomes has been even smaller. In addition, many of the sequences were collected in the course of influenza surveillance programs that prioritized antigenically novel isolates. Although collecting antigenically novel isolates is appropriate for surveillance, it results in biased samples of sequenced isolates that are not representative of community cases of influenza (2, 13). Therefore, in 2004, the National Institute of Allergy and Infectious Diseases (NIAID) launched the Influenza Genome Sequencing Project (7), which aims to rapidly sequence influenza viruses from samples collected all over the world. Viral sequences were generated at the J. Craig Venter Institute, annotated at the National Center for Biotechnology Information (NCBI), and deposited in GenBank. In just over 2 years after the initiation of the project, more than 2,000 complete genomes of influenza viruses A and B had been deposited in GenBank. To help the research community to make full use of the wealth of information from such a large amount of data, which will be increasing continuously, the Influenza Virus Resource was created at NCBI in 2004.

The influenza virus resource at the National Center for Biotechnology Information.

The evolutionary interaction between influenza A virus and the human immune system, manifest as ‘antigenic drift’ of the viral haemagglutinin, is one of the best described patterns in molecular evolution. However, little is known about the genome-scale evolutionary dynamics of this pathogen. Similarly, how genomic processes relate to global influenza epidemiology, in which the A/H3N2 and A/H1N1 subtypes co-circulate, is poorly understood. Here through an analysis of 1,302 complete viral genomes sampled from temperate populations in both hemispheres, we show that the genomic evolution of influenza A virus is characterized by a complex interplay between frequent reassortment and periodic selective sweeps. The A/H3N2 and A/H1N1 subtypes exhibit different evolutionary dynamics, with diverse lineages circulating in A/H1N1, indicative of weaker antigenic drift. These results suggest a sink–source model of viral ecology in which new lineages are seeded from a persistent influenza reservoir, which we hypothesize to be located in the tropics, to sink populations in temperate regions. Influenza is one of the most important respiratory infections of humans, responsible for 250,000 to 500,000 deaths annually 1 .O f the three types of influenza virus, type A is the most virulent and is associated with seasonal (winter) epidemics in temperate regions, more persistent transmission in the tropics 2 , and occasional largescale global pandemics characterized by increased morbidity and mortality.

/pdf/the-genomic-and-epidemiological-dynamics-of-human-influenza-55bg50qri3.pdf

The genomic and epidemiological dynamics of human influenza A virus

Influenza epidemics cause morbidity and mortality worldwide (4). Each year in the United States, more than 200,000 patients are admitted to hospitals because of influenza and there are approximately 36,000 influenza-related deaths (14). In recent years, several subtypes of avian influenza viruses have jumped host species to infect humans. The H5N1 subtype, in particular, has been reported in 328 human cases and has caused 200 human deaths in 12 countries (World Health Organization, http://www.who.int/csr/disease/avian_influenza/country /cases_table_2007_09_10/en/index.html). These viruses have the potential to cause a pandemic in humans. Antiviral drugs and vaccines must be developed to minimize the damage that such a pandemic would bring. To achieve this, it is vital that researchers have free access to viral sequences in a timely fashion, and sequence analysis tools need to be readily available. Historically, the number of influenza virus sequences in public databases has been far less than those of some well-studied viruses, such as human immunodeficiency virus. The number of complete influenza virus genomes has been even smaller. In addition, many of the sequences were collected in the course of influenza surveillance programs that prioritized antigenically novel isolates. Although collecting antigenically novel isolates is appropriate for surveillance, it results in biased samples of sequenced isolates that are not representative of community cases of influenza (2, 13). Therefore, in 2004, the National Institute of Allergy and Infectious Diseases (NIAID) launched the Influenza Genome Sequencing Project (7), which aims to rapidly sequence influenza viruses from samples collected all over the world. Viral sequences were generated at the J. Craig Venter Institute, annotated at the National Center for Biotechnology Information (NCBI), and deposited in GenBank. In just over 2 years after the initiation of the project, more than 2,000 complete genomes of influenza viruses A and B had been deposited in GenBank. To help the research community to make full use of the wealth of information from such a large amount of data, which will be increasing continuously, the Influenza Virus Resource was created at NCBI in 2004. OVERVIEW OF THE NCBI INFLUENZA VIRUS RESOURCE Access to the NCBI Influenza Virus Resource (http://www .ncbi.nlm.nih.gov/genomes/FLU/) is shown in Fig. 1. The main component of the resource is the NCBI Influenza Virus Sequence Database, where users can build queries, retrieve sequences, and find complete genome sets. The resource also provides sequence analysis tools, such as multiple-sequence alignment and clustering of protein sequences based on different metrics, that are integrated with the database. An influenza virus sequence-specific BLAST page and a genome annotation tool for influenza viruses A and B are available. In addition, the resource has links to influenza virus sequences, protein structures, the Trace Archive, publications, and general information about influenza viruses.

GUEST COMMENTARY The Influenza Virus Resource at the National Center for Biotechnology Information

Influenza viruses are remarkably adept at surviving in the human population over a long timescale. The human influenza A virus continues to thrive even among populations with widespread access to vaccines, and continues to be a major cause of morbidity and mortality. The virus mutates from year to year, making the existing vaccines ineffective on a regular basis, and requiring that new strains be chosen for a new vaccine. Less-frequent major changes, known as antigenic shift, create new strains against which the human population has little protective immunity, thereby causing worldwide pandemics. The most recent pandemics include the 1918 'Spanish' flu, one of the most deadly outbreaks in recorded history, which killed 30-50 million people worldwide, the 1957 'Asian' flu, and the 1968 'Hong Kong' flu. Motivated by the need for a better understanding of influenza evolution, we have developed flexible protocols that make it possible to apply large-scale sequencing techniques to the highly variable influenza genome. Here we report the results of sequencing 209 complete genomes of the human influenza A virus, encompassing a total of 2,821,103 nucleotides. In addition to increasing markedly the number of publicly available, complete influenza virus genomes, we have discovered several anomalies in these first 209 genomes that demonstrate the dynamic nature of influenza transmission and evolution. This new, large-scale sequencing effort promises to provide a more comprehensive picture of the evolution of influenza viruses and of their pattern of transmission through human and animal populations. All data from this project are being deposited, without delay, in public archives.

/pdf/large-scale-sequencing-of-human-influenza-reveals-the-23ua4q9uqb.pdf

Vik Subbu

Papers

Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution